Minerva Neurosciences Inc (NASDAQ: NERV)
$3.38
-0.0200 ( -0.59% ) 7.2K
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
Market Data
Open
$3.38
Previous close
$3.40
Volume
7.2K
Market cap
$23.36M
Day range
$3.33 - $3.43
52 week range
$2.26 - $13.49
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Oct 05, 2023 |
4 | Insider transactions | 1 | Sep 29, 2023 |
4 | Insider transactions | 1 | Sep 29, 2023 |
4 | Insider transactions | 1 | Sep 29, 2023 |
4 | Insider transactions | 1 | Sep 29, 2023 |
4 | Insider transactions | 1 | Sep 29, 2023 |
8-k | 8K-related | 12 | Sep 28, 2023 |
ars | Annual reports | 1 | Aug 15, 2023 |
def | Proxies and info statements | 5 | Aug 15, 2023 |
10-q | Quarterly Reports | 51 | Aug 01, 2023 |